TEHR vs MD Integrations: clinical depth and brand operations

How do the published offers compare as of October 22, 2026?

This table separates a documented offer from an unanswered procurement question. “Not stated on reviewed pages” means we did not establish the term from the cited public material; it does not mean the vendor lacks the capability. TEHR details reflect our stated offering and still require a scoped proposal.

Is the main difference clinical staffing or operational scope?

MD Integrations’ homepage emphasizes physician-only staffing. That is a legitimate buying criterion for a program whose clinical design or brand promise calls for that staffing model. It should not be converted into a claim that every other model delivers inferior care, or that physician staffing alone tells you how the brand’s billing, subscriptions and support will operate. Evaluate those dimensions separately.

TEHR provides a white-label operating platform connected to an independent licensed clinical network. Its commercial proposition includes payments, subscriptions, AI-assisted intake and administrative coordination, with service details established in the proposal. The comparison is therefore not simply doctors versus software. Ask which clinical services you need, how they will be staffed and what nonclinical work remains after the consultation. A clear answer lets you compare the complete program rather than a single visible part of it.

Why is the controlled-substance distinction important?

The MD Integrations FAQ states that it does not prescribe controlled substances. The same FAQ discusses hormone therapy, so an operator should not treat the broader category name as proof that every hormone program is supported. Write down the specific intended clinical service before asking whether the platform can support it. Have the clinical team explain available pathways and the limits that apply to your program.

TEHR program availability also requires individual review; nationwide network reach does not mean every treatment is available everywhere or appropriate for every patient. This article does not determine prescribing eligibility. The practical procurement step is to obtain a program-specific description that names the clinical decision-maker, visit requirements, follow-up expectations and fulfillment pathway. It is better to discover a mismatch during scoping than to design a brand around a category label that the underlying service cannot actually deliver.

How should you choose between an API and a ready-made experience?

MD Integrations’ FAQ describes both custom integration and an off-the-shelf white-label intake and messaging route. An API can preserve an existing product experience, but it also makes your engineering team responsible for more of the surrounding implementation. A ready-made route can reduce that work, provided it supports the patient journey, branding and commercial systems you need.

Ask for an end-to-end example in the exact route being quoted. Follow intake submission, review status, patient questions, fulfillment updates and repeat visits. Determine where your application must store identifiers, how it receives events and what staff see when an integration fails. TEHR should be assessed with the same questions. Read the white-label platform guide before deciding that an integration option and an operated brand platform are interchangeable products with different logos.

What should the total-cost request include?

MD Integrations says pricing is tailored during a demo. We did not establish a numerical rate schedule or revenue-share policy from the reviewed pages. TEHR uses a flat platform subscription and flat transaction fee with 0% revenue share; contact TEHR for a scoped quote. Without matched proposals, neither “cheapest” nor a percentage savings claim is justified.

Ask each vendor to price the same program and distinguish one-time integration work, recurring platform fees, clinical encounters, pharmacy services, tests, payment processing and optional support. Specify whether repeat messages, follow-ups, unsuccessful transactions and renewals are billable events. If a service is described as included, ask what volume and usage boundaries apply. Then model the business with your own acquisition and retention assumptions. The TEHR pricing calculator is useful for exploring inputs, not for replacing the written commercial schedule.

When should you choose TEHR?

Choose TEHR when your main requirement is a coordinated brand operating model that covers the commercial and administrative work around care. A creator, existing consumer brand or established health business may already know how to reach customers while needing a more coherent system for recurring orders and operational visibility. The right test is whether the proposed TEHR scope removes the specific work your team does not want to assemble.

TEHR’s operators built DudeMeds, Peptiders, TellyMeds and FansMeds and migrated thousands of their own patients. Ask for a demonstration that makes this experience relevant to your own program: a returning patient, a payment exception, an order investigation and a clinical escalation. Review the platform and pricing structure together. Choose the proposal if the combined services fit your needs; do not select it on an assumption that every alternative lacks commerce, support or technical flexibility.

When should you choose MD Integrations?

Choose MD Integrations when its physician-only staffing model and integration approach fit your clinical program and existing product. Its official site also identifies Shopify and WooCommerce extensions, which are relevant if your team wants to preserve an established commerce layer. Ask what those extensions cover and where additional development or operational coordination is required.

The tradeoffs depend on the program. A business requiring a controlled-substance pathway should address the FAQ’s stated exclusion immediately. A business retaining its own subscriptions and support may value a narrower clinical integration, while one seeking a broad managed operating bundle should itemize the remaining work. Request direct answers on costs, patient-history handling and change management. Choosing a clinical specialist can be a strong decision when your organization is prepared to own the complementary systems and services.

How should an existing brand assess continuity?

List active patients and the events that must continue after transition: scheduled care, unresolved questions, outstanding laboratory work, open pharmacy orders and recurring commercial charges. A migration plan should distinguish moving information from establishing a new care relationship or clinical workflow. Do not assume that importing a chart automatically moves an active prescription, a payment token or a patient’s consent for a different purpose.

A documented managed migration process for MD Integrations was not established in the reviewed pages. Ask its implementation team rather than treating that absence as a capability verdict. TEHR’s migration experience also needs a scoped plan for your source system. Use the patient migration checklist to agree on exports, mapping, validation and a controlled pilot. The goal is an observable transition with defined exceptions, not a headline about the number of records uploaded in a day.

What should a final demonstration prove?

Have the same people attend each finalist’s demonstration: your operations lead, the person responsible for commerce and someone able to evaluate clinical workflow requirements. Give each vendor a case that requires a follow-up question and another that cannot proceed through the normal path. Ask who responds, where the status appears and what the brand is allowed to tell the patient.

This reveals whether the proposed product and service boundaries match your actual business. Record unanswered questions and obtain written responses before contracting. A fast response-time claim, a polished storefront and a broad specialty list answer different questions; none alone establishes the best fit. Use MD Integrations alternatives to explore other structures, or contact TEHR with the operating brief you developed. Keep the choice grounded in delivered scope, clinical fit and controllable economics.

What else should you know?